Methodological issues for using a common data model (CDM) of COVID-19 vaccine uptake and important adverse events of interest (AEIs): the Data and Connectivity COVID-19 Vaccines Pharmacovigilance (DaC-VaP) United Kingdom feasibility study. (Preprint)
Date first appeared online | 08/03/2022 |
DOI | 10.2196/preprints.37821 |
Authors | Akbari A., Bedston S., Lyons R., Owen R. |
Journal Name | JMIR Formative Research |
Volume |